Genital Warts (Condyloma Acuminatum) Market Analysis and Opportunity Assessment 2023 to 2033

The global market for genital warts (condyloma acuminatum) is expected to be worth $1.87 billion in 2023, rising to $3 billion by 2033 at a CAGR of 4.84%. As new drugs are introduced, the dynamics of the genital warts market are expected to change in the coming years. Tamir Biotechnology (Orgenesis), Verrica Pharmaceuticals, Novan Inc., and others are developing drugs to treat genital warts. Furthermore, successful and well-communicated vaccination campaigns have raised public awareness of vaccines and their benefits, resulting in increased vaccine uptake. Furthermore, increased vaccination coverage has been linked to a decrease in genital wart occurrence.

Paladin Labs Inc., a subsidiary of Endo International plc., a pharmaceutical company, announced the July 2014 launch of Veregen (sinecatechins) Ointment, 10%, a topical treatment for external genital and perianal warts (condylomata acuminata) in immunocompetent patients aged 18 and older. Furthermore, continuous innovation in the healthcare sector increased consumer awareness and medical infrastructure investments. Several opportunities are likely to emerge in emerging and less developed countries during the forecast period, influencing market growth.

However, a lack of public awareness and understanding about vaccine accessibility and use, as well as growing concerns about the long-term side effects of therapies and expensive treatment alternatives, are expected to be significant impediments. There is a significant unmet need for targeted drugs with improved clinical profiles, lower costs, and a more convenient administration schedule. However, rising R&D spending on oncologic diseases promises a bright future for the market in the near future.

Competitive Landscape

Key players in the Genital Warts market are: Verrica Pharmaceuticals, Tamir Biotechnology, Novan Inc., Medicis Pharmaceuticals, Aresus Pharma, AbbVie, Sanofi S.A., AbbVie Inc, Perrigo Company PLC, Glenmark Pharmaceuticals. Some key developments in this market are:

Get More Insights@ https://www.futuremarketinsights.com/reports/genital-warts-condyloma-acuminatum-market

Key Segments Profiled in the Genital Warts Market Industry survey

Genital Warts Market by Treatment:

  • Chemical Treatment
  • Ablative Treatment
  • Preventive Treatment
  • Other Treatments

Genital Warts Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail pharmacies
  • Online Pharmacies

Comments

Post a Comment

Popular posts from this blog

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Cognitive Diagnostics Market Projected to Reach Unprecedented Growth by 2033

Image
As per Future Market Insights latest industry analysis, the valuation for the global  Cognitive Diagnostics market sales  is estimated to reach US$ 110.2 Billion in 2023 and is projected to exhibit a CAGR of 8.0% over the forecast period, with an estimated valuation of US$ 238.3 Billion by 2033. Several causes of brain problems or cognitive disorders include closed head injuries, contact with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on the area of the brain that is impacted, a person may have a certain form of cognitive problem. Communication issues could result from, for instance, a tumour in the speech cisterns of the brain. In another illustration, a brain infection that affects the motor recentres would cause problems with movement. Ageing is also a factor in the development of cognitive problems. Cognitive diagnostics increasingly use digital health technologies like wearables and smartphone apps. These tools can monitor a pati...
Read more